Sanalp Menekşe, TuğbaKaçer, İlkerHacımustafaoğlu, MuhammetGül, MuratAteş, Can2024-07-222024-07-2220241752-0363https:/dx.doi.org/10.2217/bmm-2023-0682https://hdl.handle.net/20.500.12451/12188The authors investigated the value of novel inflammatory markers, systemic immune-inflammation index and C-reactive protein to albumin ratio (CAR), to predict in-hospital mortality in patients with non-ST elevation myocardial infarction (NSTEMI). Materials & methods: A total of 308 patients who underwent percutaneous coronary intervention because of NSTEMI were retrospectively included in the study. Killip classification, Thrombolysis in Myocardial Infarction score, SYNTAX score, and CAR and systemic immune-inflammation index values were calculated. Results: CAR (cutoff: 0.0864; sensitivity: 94.1%; specificity: 40.5%; p = 0.008) and Killip classification (cutoff: 2.5; sensitivity: 64.7%; specificity: 8.9%; p = 0.001) were found to be significantly higher in determining in-hospital mortality. Conclusion: This study revealed that CAR is an inexpensive and significant factor in predicting in-hospital mortality in patients undergoing percutaneous coronary intervention for NSTEMI.eninfo:eu-repo/semantics/embargoedAccessC-reactive Protein to Albumin RatioIn-hospital MortalityKillipNSTEMISystemic Immune-inflammation IndexArticle18310311310.2217/bmm-2023-0682Q2N/A